IRVINE, Calif., July 25, 2023 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize ...
The dosage of Xdemvy (lotilaner ophthalmic solution) for Demodex blepharitis is typically 1 drop per eye twice daily for 6 weeks. It’s important to take the Xdemvy dosage your doctor prescribes.
Please provide your email address to receive an email when new articles are posted on .
Tarsus Pharmaceuticals, Inc. is upgraded to Strong Buy with a 12-month price target of $100/share, driven by Xdemvy's rapid commercialization. Xdemvy remains the only approved treatment for Demodex ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback